Report Code: A03631 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Complex Percutaneous Coronary Intervention Market
Request Now !Percutaneous coronary intervention (PCI) is a non-surgical procedure in which a catheter or a stent is used to open narrowed blood vessels which are blocked by deposition of plaque. It is used to improve blood flow and decrease heart-related chest pain improving the patients condition.
Rise in incidences of heart diseases, diabetes, and coronary artery disease, development of advanced stents, and introduction of cost effective intervention devices drive the market for complex percutaneous coronary intervention (PCI). However, low number of heart specialty hospitals and limited availability of heart surgeons restrain the market growth. Moreover, introduction of advanced technologies within the percutaneous coronary intervention such as advanced silicone and polymer implants in the emerging nations such as China, Brazil, and India create opportunities for the market growth during the forecast period.
The complex percutaneous coronary intervention market is segmented on the basis of types of stents, surgery, and region. On the basis of stents, it is divided into drug-eluting stents (DES), bare metal stents, and bioresorbable stents. On the basis of surgery, it is classified into percutaneous coronary intervention (PCI), transcatheter aortic valve implantation (TAVI/TAVR), and trans-mitral valve implantation (TMVR). By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players in the market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B. Braun Melsungen AG, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Terumo Corporation, Johnson & Johnson, Getinge AB, and St. Jude Medical.
Key Benefits
Complex Percutaneous Coronary Intervention Market Report Highlights
Aspects | Details |
---|---|
By Stents |
|
By Surgery |
|
By Region |
|
Key Market Players | Boston Scientific Corporation, Abbott Laboratories, B. Braun Melsungen AG, St. Jude Medical., Biosensors International Group, Ltd.,, Johnson & Johnson,, Getinge AB,, Terumo Corporation,, Medtronic plc,, Biotronik SE & Co. KG, |
Start reading.
This Report and over 67,069+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers